The Oncosearch | Oncotarget

Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint Research Paper

Jiang Chen, Tong Ji, Jie Zhao, Gaofeng Li, Jian Zhang, Renan Jin, Jinghua Liu, Xiaolong Liu, Xiao Liang, Diyu Huang, Anyong Xie, Hui Lin, Yong Cang, Xiujun Cai

Published Apr 25, 2016 · Vol. 7, No. 27 · pp. 41274-41284

ÂÂÂÂCyclic AMP efflux inhibitors as potential therapeutic agents for leukemia Research Paper

Dominique R. Perez, Yelena Smagley, Matthew Garcia, Mark B. Carter, Annette Evangelisti, Ksenia Matlawska-Wasowska, Stuart S. Winter, Larry A. Sklar, Alexandre Chigaev

Published Apr 25, 2016 · Vol. 7, No. 23 · pp. 33960-33982

Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer Research Paper

Takahiro Yoshida, Kideok Jin, Hong Song, Sunju Park, David L. Huso, Zhe Zhang, Han Liangfeng, Charles Zhu, Frank Bruchertseifer, Alfred Morgenstern, George Sgouros, Saraswati Sukumar

Published Apr 23, 2016 · Vol. 7, No. 22 · pp. 33306-33315

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma Research Paper

Friederike Braig, Minna Voigtlaender, Aneta Schieferdecker, Chia-Jung Busch, Simon Laban, Tobias Grob, Malte Kriegs, Rainald Knecht, Carsten Bokemeyer, Mascha Binder

Published Apr 22, 2016 · Vol. 7, No. 28 · pp. 42988-42995

Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells Research Paper

Stephen L. Hayward, Christina L. Wilson, Srivatsan Kidambi

Published Apr 22, 2016 · Vol. 7, No. 23 · pp. 34158-34171

Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane Research Paper

Yang Su, Katharina Tatzel, Xuejun Wang, Brian Belt, Pratibha Binder, Lindsay Kuroki, Matthew A. Powell, David G. Mutch, William G. Hawkinsand, Dirk Spitzer

Published Apr 22, 2016 · Vol. 7, No. 21 · pp. 31534-31549

Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1 Research Paper

Tanvi J. Desai, Jason E. Toombs, John D. Minna, Rolf A. Brekken, Damith Gomika Udugamasooriya

Published Apr 22, 2016 · Vol. 7, No. 21 · pp. 30678-30690

Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium) Research Paper

Sun Min Lim, Hye Ryun Kim, Eun Kyung Cho, Young Joo Min, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Byoung Chul Cho, Ji-Hyun Lee, Hye Cheol Jeong, Eun Kyung Kim, Joo-Hang Kim

Published Apr 21, 2016 · Vol. 7, No. 24 · pp. 36311-36320

Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer Research Paper

Peng Xu, Naijin Xu, Kai Guo, Abai Xu, Fumiaki Takenaka, Eiji Matsuura, Chunxiao Liu, Hiromi Kumon, Peng Huang

Published Apr 20, 2016 · Vol. 7, No. 22 · pp. 33025-33034

Cisplatin induces stemness in ovarian cancer Research Paper

Andrew Wiechert, Caner Saygin, Praveena S. Thiagarajan, Vinay S. Rao, James S. Hale, Nikhil Gupta, Masahiro Hitomi, Anil Belur Nagaraj, Analisa DiFeo, Justin D. Lathia, Ofer Reizes

Published Apr 20, 2016 · Vol. 7, No. 21 · pp. 30511-30522

CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro Research Paper

Hinrich P. Hansen, Ahmad Trad, Maria Dams, Paola Zigrino, Marcia Moss, Maximilian Tator, Gisela SchÃ¶n, Patricia C Grenzi, Daniel Bachurski, Bruno Aquino, Horst DÃ¼rkop, Katrin S Reiners, Michael von Bergwelt-Baildon, Michael Hallek, Joachim GrÃ¶tzinger, Andreas Engert, Adriana F Paes Leme, Elke Pogge von Strandmann

Published Apr 20, 2016 · Vol. 7, No. 21 · pp. 30523-30535

Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling Research Paper

Ling Yu, Zhengfu Fan, Shuo Fang, Jian Yang, Tian Gao, Bruno M. SimÃµes, Rachel Eyre, Weichun Guo, Robert B. Clarke

Published Apr 20, 2016 · Vol. 7, No. 22 · pp. 33055-33068

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis Research Paper

Xiaojuan Yang, Jiuxia Pang, Na Shen, Fei Yan, Lai-Chu Wu, Aref Al-Kali, Mark R. Litzow, Yong Peng, Robert J. Lee, Shujun Liu

Published Apr 20, 2016 · Vol. 7, No. 24 · pp. 36382-36394

The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets Review

Dawn Q. Chong, Andrew X. Zhu

Published Apr 18, 2016 · Vol. 7, No. 29 · pp. 46750-46767

The challenge of developmental therapeutics for adrenocortical carcinoma Review

Ricardo Costa, Benedito A. Carneiro, Fabio Tavora, Sachin G. Pai, Jason B. Kaplan, Young Kwang Chae, Sunandana Chandra, Peter A. Kopp, Francis J. Giles

Published Apr 18, 2016 · Vol. 7, No. 29 · pp. 46734-46749

Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014) Clinical Research Papers

Bo Pan, Ru Yao, Jie Shi, Qian-Qian Xu, Yi-Dong Zhou, Feng Mao, Yan Lin, Jing-Hong Guan, Xue-Jing Wang, Yan-Na Zhang, Xiao-Hui Zhang, Song-Jie Shen, Ying Zhong, Ya-Li Xu, Qing-Li Zhu, Zhi-Yong Liang, Qiang Sun

Published Apr 18, 2016 · Vol. 7, No. 25 · pp. 38864-38875

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment Research Paper

Rachel Isaksson Vogel, Tanya Pulver, Wiebke Heilmann, Ashley Mooneyham, Sally Mullany, Xianda Zhao, Maryam Shahi, James Richter, Molly Klein, Liqiang Chen, Rui Ding, Gottfried Konecny, Stefan Kommoss, Boris Winterhoff, Rahel Ghebre, Martina Bazzaro

Published Apr 18, 2016 · Vol. 7, No. 21 · pp. 30962-30976

The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma Research Paper

Rajeev K. Boregowda, Daniel J. Medina, Elke Markert, Michael A. Bryan, Wenjin Chen, Suzie Chen, Anna Rabkin, Michael J. Vido, Samuel I. Gunderson, Marina Chekmareva, David J. Foran, Ahmed Lasfar, James S. Goydos, Karine A. Cohen-Solal

Published Apr 18, 2016 · Vol. 7, No. 20 · pp. 29689-29707

X66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock response Research Paper

Zhixin Zhao, Jianming Zhu, Haitian Quan, Guimin Wang, Bo Li, Weiliang Zhu, Chengying Xie, Liguang Lou

Published Apr 18, 2016 · Vol. 7, No. 20 · pp. 29648-29663

Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4 Research Paper

Qi Li, Weifeng Song, Weiyu Wang, Shanshan Yao, Chuan Tian, Xun Cai, Liwei Wang

Published Apr 18, 2016 · Vol. 7, No. 20 · pp. 29749-29760

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint Research Paper

ÂÂÂÂCyclic AMP efflux inhibitors as potential therapeutic agents for leukemia Research Paper

Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer Research Paper

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma Research Paper

Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells Research Paper

Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane Research Paper

Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1 Research Paper

Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium) Research Paper

Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer Research Paper

Cisplatin induces stemness in ovarian cancer Research Paper

CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro Research Paper

Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling Research Paper

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis Research Paper

The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets Review

The challenge of developmental therapeutics for adrenocortical carcinoma Review

Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014) Clinical Research Papers

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment Research Paper

The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma Research Paper

X66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock response Research Paper

Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4 Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint Research Paper

Â­Â­Â­Â­Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia Research Paper

Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer Research Paper

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma Research Paper

Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells Research Paper

Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane Research Paper

Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1 Research Paper

Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium) Research Paper

Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer Research Paper

Cisplatin induces stemness in ovarian cancer Research Paper

CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro Research Paper

Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling Research Paper

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis Research Paper

The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets Review

The challenge of developmental therapeutics for adrenocortical carcinoma Review

Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014) Clinical Research Papers

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment Research Paper

The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma Research Paper

X66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock response Research Paper

Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4 Research Paper

ÂÂÂÂCyclic AMP efflux inhibitors as potential therapeutic agents for leukemia Research Paper